Dave Mehalick

Dave Mehalick is the Chief Executive Officer and Cofounder of Coeptis Therapeutics since October 2016. Prior to that, they worked as the Managing Director at Steeltown Consulting Group starting in March 2004.

Dave Mehalick has attended the University of Pittsburgh but has not yet completed a degree or specified a field of study.